The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach
Abstract
The administration of macrolides such as azithromycin for chronic pulmonary infection of cystic fibrosis patients has been reported to be of benefit. Although the mechanisms of action remain obscure, anti-inflammatory effects as well as interference of the macrolide with Pseudomonas aeruginosa virulence factor production have been suggested to contribute to an improved clinical outcome. In this study we used a systematic approach and analyzed the impact of azithromycin on the global transcriptional pattern and the protein expression profile of P. aeruginosa PAO1 cultures versus those in untreated controls. The most remarkable result of this study is the finding that azithromycin exhibited extensive quorum-sensing antagonistic activities. In accordance with the inhibition of the quorum-sensing systems, virulence factor production was diminished and the oxidative stress response was impaired, whereas the type III secretion system was strongly induced. Moreover, P. aeruginosa motility was reduced, which probably accounts for the previously observed impaired biofilm formation capabilities of azithromycin-treated cultures. The interference of azithromycin with quorum-sensing-dependent virulence factor production, biofilm formation, and oxidative stress resistance in P. aeruginosa holds great promise for macrolide therapy in cystic fibrosis. Clearly quorum-sensing antagonist macrolides should be paid more attention in the management of chronic P. aeruginosa infections, and as quorum-sensing antagonists, macrolides might gain vital importance for more general application against chronic infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 2×
“Forty-three differentially expressed pro tein spots (1-43) were identified by mass spectrometry from the gels of the secretome f the AZM treated PAO1 cultures (A) and twenty-six protein spots (44-69) w ere identified from the gels of the PAO1 control secretome (B).”
BackgroundFlagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Schuster, M., Lostroh, C. P., Ogi, T., & Greenberg, E. P. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2066-2079.2003 · Cited by 1,126
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I., & Iglewski, B. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2080-2095.2003 · Cited by 920
Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
KUDOH, S., AZUMA, A., YAMAMOTO, M., IZUMI, T., & ANDO, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9710075 · Cited by 582
Wolter, J. (2002) · Thorax · doi:10.1136/thorax.57.3.212 · Cited by 518
Wu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
Hassett, D. J., Ma, J., Elkins, J. G., McDermott, T. R., Ochsner, U. A., West, S. E. H., Huang, C., Fredericks, J., Burnett, S., Stewart, P. S., et al. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01672.x · Cited by 409
Dynamics of nasopharyngeal colonization by potential respiratory pathogens
García-Rodríguez, J. Á., & Fresnadillo Martínez, M. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf506 · Cited by 404
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
The response of Pseudomonas aeruginosa to iron: genetics, biochemistry and virulence
Vasil, M. L., & Ochsner, U. A. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01586.x · Cited by 366
Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung
Shaver, C. M., & Hauser, A. R. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.6969-6977.2004 · Cited by 350
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
Davies, J. C. (2002) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0550(02)00003-3 · Cited by 300
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P. M., Solis-Moya, A., & Patel, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub4 · Cited by 298
Protein Thiol Modifications Visualized In Vivo
Leichert, L. I., & Jakob, U. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020333 · Cited by 228
Pulmonary infections in patients with cystic fibrosis
RAJAN, S. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.31690 · Cited by 220
Effects of Subinhibitory Concentrations of Macrolide Antibiotics on Pseudomonas aeruginosa
Wozniak, D. J., & Keyser, R. (2004) · Chest · doi:10.1378/chest.125.2_suppl.62s · Cited by 183
Yamagishi, M., Matsushima, H., Wada, A., Sakagami, M., Fujita, N., & Ishihama, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05695.x · Cited by 163
Arevalo‐Ferro, C., Hentzer, M., Reil, G., Görg, A., Kjelleberg, S., Givskov, M., Riedel, K., & Eberl, L. (2003) · Environmental Microbiology · doi:10.1046/j.1462-2920.2003.00532.x · Cited by 163
The Influence of Azithromycin on the Biofilm Formation of Pseudomonas aeruginosa in vitro
Ichimiya, T., Takeoka, K., Hiramatsu, K., Hirai, K., Yamasaki, T., & Nasu, M. (2009) · Chemotherapy · doi:10.1159/000239440 · Cited by 156
Nouwens, A. S., Beatson, S. A., Whitchurch, C. B., Walsh, B. J., Schweizer, H. P., Mattick, J. S., & Cordwell, S. J. (2003) · Microbiology · doi:10.1099/mic.0.25967-0 · Cited by 154
Transcriptome Analysis of the Response of Pseudomonas aeruginosa to Hydrogen Peroxide
Palma, M., DeLuca, D., Worgall, S., & Quadri, L. E. N. (2003) · Journal of Bacteriology · doi:10.1128/jb.186.1.248-252.2004 · Cited by 149
Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation
Gillis, R. J., & Iglewski, B. H. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5842-5845.2004 · Cited by 144
Tateda, K., Ishii, Y., Matsumoto, T., Furuya, N., Nagashima, M., Matsunaga, T., Ohno, A., Miyazaki, S., & Yamaguchi, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2271 · Cited by 114
Wagner, V., Gillis, R. J., & Iglewski, B. H. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.011 · Cited by 108
Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS
Hogardt, M., von Roeder, M., Schreff, A. M., Eberl, L., & Heesemann, J. (2004) · Microbiology · doi:10.1099/mic.0.26703-0 · Cited by 105
Diffuse Panbronchiolitis: Role of Macrolides in Therapy
Keicho, N., & Kudoh, S. (2002) · American Journal of Respiratory Medicine · doi:10.1007/bf03256601 · Cited by 105
Diagnosis and Treatment of Cystic Fibrosis
Koch, C., & Høiby, N. (2000) · Respiration · doi:10.1159/000029503 · Cited by 96
Kawamura‐Sato, K., Iinuma, Y., Hasegawa, T., Horii, T., Yamashino, T., & Ohta, M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2869-2872.2000 · Cited by 95
Effects of Azithromycin on Clinical Isolates of Pseudomonas aeruginosa From Cystic Fibrosis Patients
Wagner, T. A., Soong, G., Sokol, S., Saiman, L. M., & Prince, A. S. (2005) · CHEST Journal · doi:10.1378/chest.128.2.912 · Cited by 87
Ordoñez, C. L., Stulbarg, M. S., Grundland, H., Liu, J. T., & Boushey, H. A. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1085 · Cited by 81
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P., Solís-Moya, A., & Patel, L. B. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub2 · Cited by 70
Activation of SoxR-Dependent Transcription in Pseudomonas aeruginosa
Kobayashi, K., & Tagawa, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh168 · Cited by 69
Wehmhöner, D., Häußler, S., Tümmler, B., Jänsch, L., Bredenbruch, F., Wehland, J., & Steinmetz, I. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.19.5807-5814.2003 · Cited by 67
Self-citationKobayashi, T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf048 · Cited by 61
New antimicrobials in the management of cystic fibrosis
Høiby, N. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.235 · Cited by 52
Improved lung function and body mass index associated with long-term use of Macrolide antibiotics
Pirzada, O. M., McGaw, J., Taylor, C. J., & Everard, M. L. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(03)00021-3 · Cited by 51
Changes in strategies for optimal antibacterial therapy in cystic fibrosis
Ratjen, F. A. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00333-2 · Cited by 48
Molinari, G., Paglia, P., & Schito, G. C. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01961867 · Cited by 47
The use of macrolide antibiotics in patients with cystic fibrosis
Saiman, L. M. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000142101.53084.f0 · Cited by 44
Azithromycin for Improving Pulmonary Function in Cystic Fibrosis
Carr, R. R., & Nahata, M. C. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d589 · Cited by 11
Cited by
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Exploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820
The world of subinhibitory antibiotic concentrations
Davies, J., Spiegelman, G. B., & Yim, G. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.006 · Cited by 750
Antibiotics as Signal Molecules
Romero, D., Traxler, M. F., López, D., & Kolter, R. (2011) · Chemical Reviews · doi:10.1021/cr2000509 · Cited by 390
Metadata
- Authors
- Nalca, Y., Jänsch, L., Bredenbruch, F., Geffers, R., Buer, J., & Häussler, S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-05
- Volume
- 50
- Issue
- 5
- Pages
- 1680-1688
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2165829657
- Cited by
- 317
- References
- 45
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.